(Q37140029)

18 August 2017

1 reference

title

Nonalcoholic fatty liver disease as a component of the metabolic syndrome (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

18 August 2017

1 reference

0 references

1 reference

1 reference

1

Mouen A Khashab

1 reference

18 August 2017

Suthat Liangpunsakul

2

1 reference

PubMed ID

18417046

18 August 2017

Naga Chalasani

series ordinal

3

1 reference

PubMed ID

18417046

18 August 2017

language of work or name

1 reference

1 February 2008

1 reference

Current gastroenterology reports

18 August 2017

1 reference

18 August 2017

10

1 reference

18 August 2017

1

1 reference

18 August 2017

73-80

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-008-0012-0

18 August 2017

0 references

cites work

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-008-0012-0

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

12 December 2020

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

1 reference

12 December 2020

The metabolic syndrome

1 reference

12 December 2020

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

12 December 2020

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

1 reference

12 December 2020

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

12 December 2020

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease

1 reference

12 December 2020

Metformin in non-alcoholic steatohepatitis.

1 reference

12 December 2020

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

12 December 2020

Fatty liver and the metabolic syndrome among Shanghai adults

1 reference

12 December 2020

A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

1 reference

12 December 2020

Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors

1 reference

12 December 2020

Endocannabinoids and the regulation of body fat: the smoke is clearing

1 reference

12 December 2020

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

1 reference

12 December 2020

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

12 December 2020

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

12 December 2020

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

1 reference

12 December 2020

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

1 reference

12 December 2020

Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

12 December 2020

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

12 December 2020

Regression of hepatic steatosis in morbidly obese persons after gastric bypass

1 reference

12 December 2020

Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity

1 reference

12 December 2020

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

12 December 2020

Prevalence of fatty liver in children and adolescents.

1 reference

12 December 2020

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.

1 reference

12 December 2020

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

12 December 2020

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

12 December 2020

Metformin in the treatment of patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

1 reference

12 December 2020

The clinicopathologic spectrum and management of nonalcoholic fatty liver disease

1 reference

12 December 2020

Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

Effect of weight reduction on hepatic abnormalities in overweight patients.

1 reference

12 December 2020

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

12 December 2020

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

1 reference

12 December 2020

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

1 reference

12 December 2020

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease

1 reference

12 December 2020

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

1 reference

12 December 2020

Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

1 reference

12 December 2020

10.1007/S11894-008-0012-0

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18417046